This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Scrutinio, D. Search for Related Content PubMed PubMed Citation Articles by Scrutinio, D.

Ticlopidine versus aspirin after myocardial infarction (stami) trial

Domenico Scrutinio, MD^*, Claudio Cimminiello, MD, Ettore Marubini, PhD, Maria Vittoria Pitzalis, MD, Matteo Di Biase, MD^||, Paolo Rizzon, MD the STAMI Group

^* Division of Cardiology, "S. Maugeri" Foundation, IRCCS, Institute of Rehabilitation, Cassano Murge, Bari, Italy
Medical Department, Azienda Ospedaliera Vimercate Hospital, Milan, Italy
Institute of Medical Statistics and Biometry, University of Milan, Milan, Italy
Institute of Cardiology, University of Bari, Bari, Italy
^|| Division of Cardiology, University of Foggia, Foggia, Italy. This study was supported by a grant from Sanofi-Synthelabo, Milan, Italy

View larger version (19K): [in a new window]   Figure 1 Incidence curves for primary end point.

View larger version (21K): [in a new window]   Figure 2 Crude cumulative incidence curves for death (A), nonfatal repeat myocardial infarction (B) and angina or nonfatal stroke (C).